Gemmus Pharma Inc. — Form D
Gemmus Pharma Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2012-06-06. The offering totals $1.8M, of which $1.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-06-06
- Form: D
- Accession: 0001550724-12-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $1.8M
- Amount sold: $1.5M
- Remaining: $340K
- Investors: 16
- Date of first sale: 2012-05-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-179356
Issuer
- Name: Gemmus Pharma Inc.
- CIK: 0001550724
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 409 ILLINOIS STREET, SAN FRANCISCO, CA, 94158
- Phone: 415-978-2151
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Marc Rubin | Director | Denver, CO |
| Christopher Dunn | Director | Kansas City, MO |
| William Guilford | Director | San Francisco, CA |
| William Guilford | Executive Officer | San Francisco, CA |
| William Holstein | Executive Officer | San Francsico, CA |
| Larry Miller | Director | San Francisco, CA |
| Daryl Faulds | Director | San Francisco, CA |
| Daryl Faulds | Executive Officer | San Francisco, CA |
Other filings by this issuer (1)
More